Neurosense Therapeutics Ltd. (NRSN) has released an update.
NeuroSense Therapeutics Ltd. has announced a pre-funded warrants offering, allowing holders to purchase ordinary shares at a nominal exercise price, with the option for a cashless exercise if certain conditions are met. The purchase agreement was established on April 10, 2024, and the warrants can be exercised at any time before the termination date. The company emphasizes that no additional consideration beyond the nominal exercise price is necessary for warrant holders to participate in this offering.
For further insights into NRSN stock, check out TipRanks’ Stock Analysis page.
